Structural Genomix in $11M Deal with Cystic Fibrosis Foundation | GenomeWeb

NEW YORK, Feb 8 - Structural Genomix said Thursday it reached an agreement with the Cystic Fibrosis Foundation to determine the structure of a protein, cystic fibrosis transmembrane regulator, which is involved in causing cystic fibrosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.